Webinars Overview
As healthcare continues to evolve, novel drug modalities such as oligonucleotides, peptides, and antibody-drug conjugates (ADCs) offer transformative potential. Despite their promise, these molecules present significant DMPK challenges in development due to their complex structures and unique mechanisms of action. This webinar will explore essential aspects of in vitro metabolism studies and bioanalytical strategies critical for the successful development and optimization of these therapies.
Complete the form to view this webinar.
Stay Connected
Keep up with the latest news and insights.